potential best-in-class CETP inh. (<1 mg QD)

completed Ph. I in HV; discont. as backup

from anacetrapib

Journal of Medicinal Chemistry

Merck & Co., Kenilworth, NJ, USA

MK-8262

The Merck CETP inhibitor backup, MK-8262, is potential best-in-class CETP inhibitor, which was only discontinued as a backup due to the success of its predecessor, anacetrapib in Ph. III. Reviewer Kim…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: